YCBD: Kapitalisasi marang pendapatan cbdMD Inc.

Logo korporat perusahaan cbdMD Corp (YCBD)

The historical P/S trend illustrates the valuation dynamics of cbdMD, Inc. (YCBD), where the metric stands at 0.20. Business growth relies on the scalability of D2C sales combined with partial outsourcing of production. The product range covers the wellness segment for humans and pets via omnichannel distribution. Currently, cbdMD, Inc. (YCBD) is focusing on organic growth and margin optimization while conducting a deep restructuring of its debt and operational processes.

cbdMD Corp - Multiplikator P/S YCBD (periode 04.07.2022 - 13.11.2026)

Rincian analitis perusahaan cbdMD, Inc. (YCBD)

- rega saham lan konsensus proyeksi valuasi:
- informasi kapitalisasi pasar:
Ringkesan analitik perusahaan:cbdMD Inc., YCBD
Produk asli cbdMD Inc.

To objectively assess the operational efficiency of cbdMD, Inc. (YCBD), investors must compare the business's market value with its generated sales volume. By analyzing the current P/S multiple on the GURU.Markets platform, you determine how many dollars of capitalization the market is willing to pay per unit of revenue, which is critical for a wellness ecosystem utilizing a recurring subscription model that ensures stable cash flow and high consumer loyalty.

Perusahaan pesaing

HLN (haleon.com) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S KVUE (Kenvue)|VRNA - Kapitalisasi marang pendapatan|Jyong Biotech Corp - Multiplikator P/S|LGND: Rasio rega marang pendapatan|AMRX: Multiplikator P/S|Rasio kapitalisasi marang pendapatan PRGO|Rasio rega marang pendapatan Alvotech SA|Kapitalisasi marang pendapatan Liquidia Corp (LQDA)|Multiplikator P/S GLPG|ANI Pharmaceuticals Corp - Rasio kapitalisasi marang pendapatan|MannKind Corporation - Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan AMPH|Pacira BioSciences, Inc. - Multiplikator P/S|Koefisien rega marang pendapatan ARS Pharmaceuticals Inc SPRY|Theravance (TBPH) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan AQST|SCPH (scPharmaceuticals, Inc.) - Multiplikator P/S|Kapitalisasi marang pendapatan Tectonic (TECX)|Kapitalisasi marang pendapatan TNXP (Tonix Pharmaceuticals Holding Corp.)|Koefisien rega marang pendapatan sxtchina.com|Eupraxia Pharmaceuticals Inc. - Kapitalisasi marang pendapatan|BioHarvest Sciences Inc (BHST) - Rega marang dodolan|eXoZymes Inc - Multiplikator P/S|Oramed Pharmaceuticals (ORMP) - Kapitalisasi marang pendapatan|ENTX: Multiplikator P/S|HYFT (MindWalk Holdings, Inc.) - Rasio rega marang pendapatan|ABVC (ABVC BioPharma Inc) - Multiplikator P/S|Rasio kapitalisasi marang pendapatan CPIX (Cumberland Corp)|Rasio rega marang pendapatan Quantum BioPharma Ltd (QNTM)|FGEN: Rasio rega marang dodolan|Multiplikator P/S TELO (Telomir Pharmaceuticals, Inc.)|Rasio kapitalisasi pasar marang pendapatan RANI|Synergy CHC Corporation - Multiplikator P/S|RLYB - Multiplikator P/S|lexariabioscience.com (LEXX) - Rasio rega marang pendapatan|pulmatrix.com - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Pheton Holdings Limited|Kapitalisasi marang pendapatan Aptorum (APM)|Multiplikator P/S LYRA|Multiplikator P/S Impact BioMedical, Inc. (IBO)|TNF Pharmaceuticals, Inc. - Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan PRFX|CYTO - Rasio rega marang pendapatan|Rega marang dodolan Lipella Pharmaceuticals Inc|OPTN (Optinose) - Kapitalisasi marang pendapatan|PIRS: Kapitalisasi marang volume dodolan|PROC (Procaps Group S.A.) - Multiplikator P/S|PTPI: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S QLI|SLRN - Rega marang dodolan|Rasio rega marang pendapatan TFF Pharma TFFP